Read More 5 minute read Pharma Industry News Regencell Bioscience shares surge over 70% amid ADHD, autism hype Regencell Bioscience stock soared over 70% in a day, extending YTD gains past 6,500%—see what’s driving this biotech’s speculative surge in ADHD and autism. byPallavi MadhirajuMay 10, 2025